Wednesday
• Posted by Provider Relations
Fidelis Care would like to inform providers of a postpartum visit incentive being offered through the New York State (NYS) Medicaid program. This program will provide an additional payment to the current NYS Medicaid reimbursement for comprehensive, timely postpartum visits provided to Medicaid Managed Care (MMC)/Fidelis Care Medicaid members. The incentive payment will apply to postpartum visits for deliveries that occurred from July 1, 2024, through March 31, 2025.
Providers who delivered a person-centered comprehensive postpartum visit as outlined by the American College of Obstetricians and Gynecologists clinical guidelines, including a postpartum depression screen, to Fidelis Care members within 12 weeks
Last Week
• Posted by Fidelis Care
紐約長島市(2025年6月10日)飛達利斯保健是一個在全州營運的健康計劃,在紐約州擁有逾240萬名會員,是Centene公司的旗下公司,已啟動2025年產婦健康補助金計劃的申請流程。 該補助金面向紐約州內的醫療服務提供者及社區組織開放,旨在為支援產後護理及產婦心理健康創新策略的計劃提供資金支援。該申請表可在fideliscare.org/maternal-grant上找到。申請截止時間為2025年7月8日下午5點。
Last Week
• Posted by Provider Relations
Fidelis Care would like to remind providers of the appropriate coding modifiers to use when billing for a surgical or diagnostic procedure that was discontinued or stopped prior to completion for both facilities and physicians.
Modifiers 73/74 are specifically used by facilities, to indicate that a procedure was discontinued or stopped prior to completion. Coinciding with these facility modifiers, physicians should bill modifiers 52/53, which also indicates that a procedure was discontinued or cancelled. If a procedure has been discontinued, both facility and physician claim submissions should reflect the discontinuation, by using the appropriate modifier codes below.
Facility Modifier Codes:
Modifier 73:
2025/6/25
• Posted by Provider Relations
The following section of the Fidelis Care authorization grids have been updated effective August 1, 2025.
The following code has been added on the Medicare, Medicaid, Essential Plan, and Metal-Level Products Authorization Grids and require prior authorization:
III. Outpatient surgery:
P. CAR-T Therapy: Q2058
Visit: Authorization Grids
2025/6/24
• Posted by Provider Relations
Fidelis Care will host three Provider Office Hours in July 2025. During the webinar, Fidelis Care staff will be available to share information, provide an overview of provider resources, and answer your questions.
Provider Office Hours – July 2025
Topic: Fidelis Care – Back to Basics
When: Thursday, July 10th – 9AM – 10AM EST
Click here to register*
Topic: Claims and COB Overview
When: Thursday, July 24th – 2PM – 3PM EST
Click here to
2025/6/20
• Posted by Provider Relations
Fidelis Care would like to remind our providers of plan changes for Ambetter From Fidelis Care and Essential Plans in response to a recent NY Senate Bill addressing copayments for PrEP and PEP medications. The in-network cost share for members will be waived for medications used for PrEP and PEP, provided that an appropriate ICD-10 diagnosis code is documented on the prescription sent to the Pharmacy.
Below are updated lists of medications indicated for PrEP and/or PEP.
PrEP Medications:
Descovy Tab 200-25 MG
Apretude INJ 600 MG/3 ML
Tuvada 200-300MG; Emtricitabine-tenofovir 200-300MG
PEP Medications:
Tivicay Tab 50 MG
Isentress Tab 400 MG
Darunavir
Older Articles